CoaguSense Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

  • Investors
  • 2

CoaguSense General Information

Description

Developer of a coagulation in-vitro diagnostics and monitoring system designed to offer point-of-care prothrombin time (PT) and international normalized ratio (INR) monitoring. The company's portable system uses clot detection technology that reduces the possibility of interference from blood constituents not involved in clot formation and offers rapid testing time, simplicity, and analytical results that correlate well with the leading methods of prothrombin time (PT) determination, providing physicians and patients with accurate and precise testing devices for determining prothrombin time.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 48389 Fremont Boulevard
  • Suite 106
  • Fremont, CA 94538
  • United States
+1 (510)
Primary Industry
Other Devices and Supplies
Parent Company
Vertical(s)
Corporate Office
  • 48389 Fremont Boulevard
  • Suite 106
  • Fremont, CA 94538
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CoaguSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 22-Oct-2021 $10M Completed Generating Revenue
2. Seed Round 21-Nov-2016 Completed Generating Revenue
1. Merger/Acquisition 01-Jan-2016 Completed Generating Revenue
To view CoaguSense’s complete valuation and funding history, request access »

CoaguSense Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view CoaguSense’s complete cap table history, request access »

CoaguSense Patents

CoaguSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20030180824-A1 The reaction chamber is coated with a dry coagulation initiator (throboplastin, kaolin or diatomaceous earth) and a timer that measures an interval of time between blood is received and the clot is formed in the reaction chamber Active 25-Mar-2002
US-7235213-B2 The reaction chamber is coated with a dry coagulation initiator (throboplastin, kaolin or diatomaceous earth) and a timer that measures an interval of time between blood is received and the clot is formed in the reaction chamber Inactive 25-Mar-2002

CoaguSense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoaguSense Acquisitions (1)

CoaguSense’s most recent deal was a Merger/Acquisition with DOASENSE. The deal was made on 22-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DOASENSE 22-Mar-2026 Merger/Acquisition Diagnostic Equipment
To view CoaguSense’s complete acquisitions history, request access »

CoaguSense FAQs

  • When was CoaguSense founded?

    CoaguSense was founded in 2008.

  • Where is CoaguSense headquartered?

    CoaguSense is headquartered in Fremont, CA.

  • What is the size of CoaguSense?

    CoaguSense has 43 total employees.

  • What industry is CoaguSense in?

    CoaguSense’s primary industry is Other Devices and Supplies.

  • Is CoaguSense a private or public company?

    CoaguSense is a Private company.

  • What is the current valuation of CoaguSense?

    The current valuation of CoaguSense is .

  • What is CoaguSense’s current revenue?

    The current revenue for CoaguSense is .

  • How much funding has CoaguSense raised over time?

    CoaguSense has raised $15M.

  • When was CoaguSense acquired?

    CoaguSense was acquired on 22-Oct-2021.

  • Who acquired CoaguSense?

    CoaguSense was acquired by i-SENS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process